Search

everythinglearnresearchcommunity

for

Search:↓

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

Women with PCOS have lower amylin levels, which are not related to their body weight.

Working night shifts for four days can lower the body's ability to use insulin, which may increase the risk of type 2 diabetes.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

The study suggests that being overweight or obese, not PCOS itself, is strongly linked to insulin resistance.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Some supplements and hormones can increase hair loss by raising DHT levels.

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Early-onset male hair loss is linked to metabolic syndrome, suggesting a need for heart health monitoring and lifestyle changes.

People with polycystic ovary syndrome are more likely to have poor sleep, restless legs syndrome, anxiety, and depression.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Being overweight can cause or worsen skin problems in children, some more common in darker skin, and is often linked to insulin resistance.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Quercetin may help with PCOS symptoms, but more research is needed.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.